Romanian pharma company Antibiotice will expand in Moldova and Ukraine, a statement by the Bucharest Stock Exchange (BVB) released on Monday said. This is the second Romanian state owned company that takes steps to expand abroad, after Romanian gas grid operator Transgaz.
Last year, Antibiotice recorded a net profit of over 33.5 million, up by 1.1 percent year-on-year.
The company’s share dropped by 0.12 percent since the start of the year, and in the past month by 1.48 percent.
Antibiotice records a 5.3 percent sales increase year-on-year in pharmacies and hospitals. The retail segment is up by 5.7 percent year-on-year, from EUR 223.6 million to RON 236.3 million, while the hospitals segment up by 4 percent, from RON 76.5 million in 2016, to RON 79.5 million in 2017, data released by the BVB shows.
At the end of February, Romanian gas grid operator Transgaz, a state-owned monopoly, won the bid for the purchase of Moldova’s Vestmoldtransgaz, which operates the Moldovan section of the Iasi-Ungheni gas pipeline.